Global Cord Blood Corp
OTC:CORBF

Watchlist Manager
Global Cord Blood Corp Logo
Global Cord Blood Corp
OTC:CORBF
Watchlist
Price: 0.95 USD Market Closed
Market Cap: $127.2m

Global Cord Blood Corp
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Global Cord Blood Corp
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Global Cord Blood Corp
OTC:CORBF
Long-Term Debt
¥0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Beijing Health (Holdings) Ltd
HKEX:2389
Long-Term Debt
HK$2.1m
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
-30%
Human Health Holdings Ltd
HKEX:1419
Long-Term Debt
HK$54.2m
CAGR 3-Years
-18%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Town Health International Medical Group Ltd
HKEX:3886
Long-Term Debt
HK$37.1m
CAGR 3-Years
9%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
China Biotech Services Holdings Ltd
HKEX:8037
Long-Term Debt
HK$197m
CAGR 3-Years
45%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Bamboos Health Care Holdings Ltd
HKEX:2293
Long-Term Debt
HK$538k
CAGR 3-Years
-27%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
No Stocks Found

Global Cord Blood Corp
Glance View

Market Cap
127.2m USD
Industry
Health Care

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,215 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

CORBF Intrinsic Value
Not Available

See Also

What is Global Cord Blood Corp's Long-Term Debt?
Long-Term Debt
0 CNY

Based on the financial report for Mar 31, 2022, Global Cord Blood Corp's Long-Term Debt amounts to 0 CNY.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett